Our Services
Medical Information
Helpful Resources
Published on: 10/1/2026
Vaginal yeast infection treatments vary in length: single-dose options like oral fluconazole or a 1-day miconazole ovule work in one application, while over-the-counter antifungal creams and suppositories come in 3-day and 7-day courses. Symptom relief usually begins within 1 to 3 days, though complete clearing can take up to a week, and complicated or recurrent infections may require 7 to 14 days of treatment plus a maintenance regimen lasting up to 6 months. Choosing between these depends on symptom severity, pregnancy status, infection history, and whether the cause is truly yeast, so several important factors are explained below.
Because bacterial vaginosis, trichomoniasis, and irritant reactions can mimic yeast symptoms, treating the wrong condition wastes days of discomfort. Take a free, instant, online symptom check to clarify what your symptoms suggest and get guidance on the right next steps.
Last reviewed for medical accuracy: 10/01/2026
A vaginal yeast infection (vulvovaginal candidiasis) affects up to 75% of women at least once in their lives. It’s caused by an overgrowth of the fungus Candida and leads to symptoms like itching, burning, and unusual discharge. The good news is that effective treatments exist. Below, we break down each option, how long it takes to work, and what to expect.
Most uncomplicated yeast infections can be treated at home. However, see a doctor if you experience:
If you’re unsure about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker before deciding on treatment.
Always speak to a doctor about anything that could be life-threatening or serious.
OTC antifungals are the first‐line choice for uncomplicated infections. They come as creams, ointments, tablets, or suppositories.
If OTC options fail or infections recur, prescription medications may be needed.
Recurrent infections (four or more per year) need a different approach:
While not substitutes for antifungals, these steps can support healing:
These measures don’t cure infections on their own, but they can speed recovery and reduce recurrence.
| Treatment | Dosage/Form | Onset of Relief | Total Duration |
|---|---|---|---|
| OTC 1-Day (butoconazole/tioconazole) | Single vaginal dose | ~24 hours | ~3 days |
| OTC 3-Day (miconazole/clotrimazole) | Daily cream/suppository | ~2 days | ~4 days |
| OTC 7-Day (miconazole/clotrimazole) | Daily cream/suppository | ~3–4 days | ~7 days |
| Oral fluconazole | 150 mg single dose | 24–48 hours | ~3 days |
| Prescription azole cream/suppository | Terconazole or nystatin | 2–3 days | 3–7 days |
| Maintenance fluconazole | 150 mg weekly | Weeks to months | 6 months |
| Boric acid vaginal suppository | 600 mg daily | 3–5 days | 14 days |
For added peace of mind, you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
Always speak to a doctor about anything that could be life-threatening or serious.
(References)
* Kaplan B, Royburt M, Rabinerson D, Neri A. Once-daily fluocinonide-bifonazole combination for the treatment of vulvar itching and vulvovaginal candidiasis. Preliminary study. Clin Exp Obstet Gynecol. 1996;23(3):173-6. PMID: 8894328.
* TOTH B. [TREATMENT OF VAGINAL CANDIDISSIS WITH AQUEOUS SOLUTION OF SODIUM PENTACHLORPHENOL]. Orv Hetil. 1964 Sep 13;105:1755-7. PMID: 14195096.
* GIORLANDO SW, TORRES JF, MUSCILLO G. NEW ANTIFUNGAL ANTIBIOTIC PREPARATION: CLINICAL DOSE STUDY. Am J Obstet Gynecol. 1964 Oct 1;90:370-3. PMID: 14212794.
* MELGES FJ. A NEW ANTIFUNGAL ANTIBIOTIC. Obstet Gynecol. 1964 Dec;24:921-3. PMID: 14244878.
* GRAY LA, BARNES ML. VAGINITIS IN WOMEN, DIAGNOSIS AND TREATMENT. Am J Obstet Gynecol. 1965 May 1;92:125-36. doi: 10.1016/0002-9378(65)90113-4. PMID: 14280903.
* Skliar TV, Krysenko AV, Sirokvasha EA, Vinnikov AI. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens]. Mikrobiol Z. 2007 May-Jun;69(3):57-62. PMID: 17682532.
* Bradford LL, Chibucos MC, Ma B, Bruno V, Ravel J. Vaginal Candida spp. genomes from women with vulvovaginal candidiasis. Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx061. PMID: 28582496; PMCID: PMC5827580.
* Sherry L, Kean R, McKloud E, O'Donnell LE, Metcalfe R, Jones BL, Ramage G. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole. Antimicrob Agents Chemother. 2017 Sep;61(9). doi: 10.1128/AAC.01065-17. Epub 2017 Aug 24. PMID: 28696240; PMCID: PMC5571368.
* Sobel JD, Borroto-Esoda K, Azie N, Angulo D. In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0056221. doi: 10.1128/AAC.00562-21. Epub 2021 Jul 16. PMID: 34001513; PMCID: PMC8284466.
* Ibrahim FM, Shalaby ES, Abdelhameed MF, El-Akad RH, Ahmed KA, Abdel-Aziz MS, El Habbasha ES, Rodrigues CV, Pintado M. Bioactive Potential of Chitosan-Oleic Acid Nanoparticles Loaded with Lemon Peel Essential Oil for Topical Treatment of Vulvovaginal Candidiasis. Molecules. 2024 Dec 6;29(23). doi: 10.3390/molecules29235766. Epub 2024 Dec 6. PMID: 39683923; PMCID: PMC11643761.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.